AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22487197 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents and adults with 25(OH)D levels ≤50 nmol/L in summer/autumn
Number of subjects: 2075
Study 22487197 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents and adults with 25(OH)D levels ≤25 nmol/L in summer/autumn
Number of subjects: 2075
Study 22487197 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents and adults with highest category of sun exposure in winter/spring
Number of subjects: 2075
Study 20737278 — intervention group
Group type: EXPERIMENTAL
Intervention: Local warming at injection site using an air‐warming device at 40°C for 1 minute prior to injecting 1 ml (10 mg) of rocuronium.
Number of subjects: 90
Study 20737278 — intervention group
Group type: COMPARATOR
Intervention: Control group (no warming).
Number of subjects: 90
Study 20737278 — intervention group
Group type: EXPERIMENTAL
Intervention: Local warming at injection site.
Number of subjects: 90
Study 18614726 — intervention group
Group type: COMPARATOR
Intervention: F+0 (control) - 6 microg Se/L
Number of subjects: 161
Study 18614726 — intervention group
Group type: EXPERIMENTAL
Intervention: F+7 - 13 microg Se/L
Number of subjects: 161
Study 18614726 — intervention group
Group type: EXPERIMENTAL
Intervention: F+15 - 21 microg Se/L
Number of subjects: 161
Study 18614726 — intervention group
Group type: EXPERIMENTAL
Intervention: BF - breastfed reference group (11 +/- 2 microg Se/L)
Number of subjects: 161
Study 15905981 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient ischemic attack (TIA)
Number of subjects: 548
Study 15905981 — intervention group
Group type: COMPARATOR
Intervention: Stroke
Number of subjects: 548
Study 15905981 — intervention group
Group type: EXPERIMENTAL
Intervention: TIA
Number of subjects: 548
Study 12368787 — intervention group
Group type: EXPERIMENTAL
Intervention: Subacromial injection of a mixture of 0.5 mL (2.5 mg) betamethasone acetate and 3 mL of radiographic contrast material (iotrolan) and 7 mL of 1% lidocaine
Number of subjects: 53
Study 12368787 — intervention group
Group type: COMPARATOR
Intervention: Intradeltoid injection
Number of subjects: 53
Study 12368787 — intervention group
Group type: EXPERIMENTAL
Intervention: Subacromial injection
Number of subjects: 53
Study 10402406 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (follicles aspirated before leading follicle was 10 mm)
Number of subjects: 19
Study 10402406 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (follicles aspirated when dominant follicle was >10 mm)
Number of subjects: 19
Study 7745355 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifenprodil tartrate (60 mg a.d.)
Number of subjects: 94
Study 7745355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 2292326 — intervention group
Group type: EXPERIMENTAL
Intervention: sobrerol granules 900 mg/day for up to 10 days
Number of subjects: 40
Study 2292326 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 31492117 — intervention group
Group type: EXPERIMENTAL
Intervention: UKOS study (randomised study comparing two modes of neonatal ventilation)
Number of subjects: 0
Study 31492117 — intervention group
Group type: COMPARATOR
Intervention: Virus study (observational study examining the impact of viral lower respiratory tract infections)
Number of subjects: 0
Study 31492117 — intervention group
Group type: EXPERIMENTAL
Intervention: UKOS study
Number of subjects: 0
Study 31492117 — intervention group
Group type: COMPARATOR
Intervention: Virus study
Number of subjects: 0
Study 29317414 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual therapy (VT) for 8 weeks, performing 3-5 upper limb exercises individualized to impairment severity and preference
Number of subjects: 60
Study 29317414 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual therapy (VT) for 8 weeks
Number of subjects: 60
Study 29317414 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60
Study 27440543 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.4 g PS esters-enriched soy milk powder (2.0 g/d free PS in 30 g soy milk powder)
Number of subjects: 170
Study 27440543 — intervention group
Group type: COMPARATOR
Intervention: Placebo soy milk powder
Number of subjects: 170
Study 24721483 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound
Number of subjects: 2759
Study 24721483 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound performed by a radiologist
Number of subjects: 2759
Study 24721483 — intervention group
Group type: EXPERIMENTAL
Intervention: CT
Number of subjects: 2759
Study 22564085 — intervention group
Group type: EXPERIMENTAL
Intervention: Humor in advertisements
Number of subjects: 0
Study 22564085 — intervention group
Group type: COMPARATOR
Intervention: Nondistracting positive stimuli
Number of subjects: 0
Study 22564085 — intervention group
Group type: COMPARATOR
Intervention: Neutral stimuli
Number of subjects: 0
Study 20409444 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant continuation
Number of subjects: 70
Study 20409444 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant discontinuation
Number of subjects: 70
Study 17032708 — intervention group
Group type: EXPERIMENTAL
Intervention: Living Well with a Disability program
Number of subjects: 246
Study 15937373 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 69
Study 15937373 — intervention group
Group type: COMPARATOR
Intervention: Ayurveda
Number of subjects: 69
Study 15937373 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 69
Study 12481893 — intervention group
Group type: EXPERIMENTAL
Intervention: Hib conjugate vaccine
Number of subjects: 0
Study 10717833 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A: 100 mg/m2 i.a. cisplatin followed by 5 day continuous intravenous infusion of 5‐fluorouracil (1 g/m2 per day)
Number of subjects: 103
Study 10717833 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen B: i.a. high pressure chemo‐perfusion with 150 mg/m2 cisplatin and simultaneous intravenous infusion of 9 g/m2 sodium thiosulfate
Number of subjects: 103
Study 7738934 — intervention group
Group type: EXPERIMENTAL
Intervention: Hodge pessary with support
Number of subjects: 18
Study 7738934 — intervention group
Group type: EXPERIMENTAL
Intervention: Super tampon
Number of subjects: 18
Study 7738934 — intervention group
Group type: COMPARATOR
Intervention: No mechanical device
Number of subjects: 18
Study 1962942 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenoportography and arteriography of the liver with maiodyl
Number of subjects: 0
Study 7025875 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural morphine (10 mg)
Number of subjects: 0
Study 7025875 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular morphine (10 mg)
Number of subjects: 0
Study 31571339 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pulsed and thermal radiofrequency (Group A)
Number of subjects: 40
Study 31571339 — intervention group
Group type: COMPARATOR
Intervention: Thermal radiofrequency alone (Group B)
Number of subjects: 40
Study 31145045 — intervention group
Group type: EXPERIMENTAL
Intervention: HEI-2010 composite scores
Number of subjects: 133
Study 31145045 — intervention group
Group type: EXPERIMENTAL
Intervention: Total dairy
Number of subjects: 133
Study 31145045 — intervention group
Group type: EXPERIMENTAL
Intervention: Total vegetable
Number of subjects: 133
Study 31145045 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium
Number of subjects: 133
Study 31145045 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined calories from solid fats, alcoholic beverages, and added sugars
Number of subjects: 133
Study 25647773 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin supplementation with noise-cancelling headphones and eye masks for 3 days
Number of subjects: 12
Study 25647773 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 12
Study 23978192 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Bronchitis (CB+)
Number of subjects: 234
Study 23978192 — intervention group
Group type: COMPARATOR
Intervention: No Chronic Bronchitis (CB-)
Number of subjects: 234
Study 23978192 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe Chronic Bronchitis (SCB+)
Number of subjects: 234
Study 23978192 — intervention group
Group type: COMPARATOR
Intervention: No Severe Chronic Bronchitis (SCB-)
Number of subjects: 234
Study 21106930 — intervention group
Group type: COMPARATOR
Intervention: Yellow-flesh potatoes (YP)
Number of subjects: 36
Study 21106930 — intervention group
Group type: COMPARATOR
Intervention: Purple-flesh potatoes (PP)
Number of subjects: 36
Study 21106930 — intervention group
Group type: EXPERIMENTAL
Intervention: White-flesh potatoes (WP)
Number of subjects: 36
Study 19994615 — intervention group
Group type: EXPERIMENTAL
Intervention: Supreme Laryngeal Mask Airway (SLMA)
Number of subjects: 85
Study 19994615 — intervention group
Group type: COMPARATOR
Intervention: I-gel Supraglottic Airway (IGSA)
Number of subjects: 85
Study 19994615 — intervention group
Group type: EXPERIMENTAL
Intervention: Supreme Laryngeal Mask Airway (SLMA) and I-gel Supraglottic Airway (IGSA)
Number of subjects: 85
Study 17885010 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy germ pasta (80-g serving/d)
Number of subjects: 62
Study 15166388 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg daily for 2 weeks
Number of subjects: 12
Study 15166388 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 12
Study 11599834 — intervention group
Group type: EXPERIMENTAL
Intervention: ADCON-L gel
Number of subjects: 398
Study 11599834 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 398
Study 9479681 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-Administered Dissociative States Scale (CADSS)
Number of subjects: 0
Study 9479681 — intervention group
Group type: COMPARATOR
Intervention: Other psychiatric disorders and healthy subjects
Number of subjects: 0
Study 8305411 — intervention group
Group type: EXPERIMENTAL
Intervention: High-unsaturated fat diet
Number of subjects: 5
Study 8305411 — intervention group
Group type: EXPERIMENTAL
Intervention: High-saturated fat diet
Number of subjects: 5
Study 8305411 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 5
Study 8305411 — intervention group
Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 5
Study 2494567 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-protein diet
Number of subjects: 10
Study 2494567 — intervention group
Group type: COMPARATOR
Intervention: High-protein diet
Number of subjects: 10
Study 30646198 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular exercise during pregnancy (16-week supervised exercise program including aerobic and resistance training, 60-minute sessions, 3 times per week)
Number of subjects: 639
Study 30646198 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular exercise during pregnancy
Number of subjects: 639
Study 30646198 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 639
Study 29202548 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoker Diabetics (n=45)
Number of subjects: 90
Study 29202548 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsmoker Diabetics (n=45)
Number of subjects: 90
Study 29202548 — intervention group
Group type: COMPARATOR
Intervention: Healthy Controls (n=10)
Number of subjects: 90
Study 25879513 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose-sweetened beverage consumption three times per day for 2 weeks
Number of subjects: 19
Study 25879513 — intervention group
Group type: COMPARATOR
Intervention: Aspartame-sweetened beverage consumption three times per day for 2 weeks
Number of subjects: 19
Study 23672733 — intervention group
Group type: EXPERIMENTAL
Intervention: SILE program (structured individual‐based lifestyle education) delivered by registered dietitians over 4 sessions during 6 months
Number of subjects: 193
Study 23672733 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 193
Study 23672733 — intervention group
Group type: EXPERIMENTAL
Intervention: SILE program
Number of subjects: 193
Study 22166044 — intervention group
Group type: EXPERIMENTAL
Intervention: modular multi‐modal exercise intervention group
Number of subjects: 90
Study 22166044 — intervention group
Group type: COMPARATOR
Intervention: usual medical care group
Number of subjects: 90
Study 19502032 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentax‐AWS airway scope
Number of subjects: 520
Study 19502032 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 520
Study 17034278 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic combination therapy
Number of subjects: 292
Study 17034278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study 15064026 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide spraying
Number of subjects: 7080
Study 15064026 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of pit latrines
Number of subjects: 7080
Study 15064026 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 7080
Study 11349393 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone treatment
Number of subjects: 92
Study 9608970 — intervention group
Group type: EXPERIMENTAL
Intervention: granisetron (40 micrograms.kg‐1, n = 40)
Number of subjects: 80
Study 9608970 — intervention group
Group type: COMPARATOR
Intervention: droperidol (50 micrograms.kg‐1, n = 40)
Number of subjects: 80
Study 8157197 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser excision
Number of subjects: 80
Study 8157197 — intervention group
Group type: COMPARATOR
Intervention: Loop diathermy (LLETZ)
Number of subjects: 80
Study 3280615 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 2 mg
Number of subjects: 8
Study 3280615 — intervention group
Group type: COMPARATOR
Intervention: Flurazepam 30 mg
Number of subjects: 8
Study 30325913 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training Group (ETG)
Number of subjects: 16
Study 30325913 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training Group (RTG)
Number of subjects: 16
Study 26656669 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 42
Study 26656669 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 42
Study 26656669 — intervention group
Group type: COMPARATOR
Intervention: Both LSG and LRYGB
Number of subjects: 42
Study 26656669 — intervention group
Group type: COMPARATOR
Intervention: Diabetic patients
Number of subjects: 42
Study 26656669 — intervention group
Group type: COMPARATOR
Intervention: Preoperative indirect calorimetry and DEXA results
Number of subjects: 42
Study 25603738 — intervention group
Group type: COMPARATOR
Intervention: Microwave Diathermy Group (heated by microwave before stretching)
Number of subjects: 50
Study 25603738 — intervention group
Group type: COMPARATOR
Intervention: Treadmill Group (warm-up walking before stretching)
Number of subjects: 50
Study 25603738 — intervention group
Group type: COMPARATOR
Intervention: 30-Second Group (30 s of stretching)
Number of subjects: 50
Study 25603738 — intervention group
Group type: COMPARATOR
Intervention: 10-Minute Group (stretching for 10 min)
Number of subjects: 50
Study 25603738 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no specific intervention)
Number of subjects: 50
Study 23088252 — intervention group
Group type: EXPERIMENTAL
Intervention: Thulium laser vaporesection of the prostate
Number of subjects: 80
Study 23088252 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate
Number of subjects: 80
Study 20849542 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA‐IPL PDT
Number of subjects: 26
Study 20849542 — intervention group
Group type: COMPARATOR
Intervention: IPL only
Number of subjects: 26
Study 19060423 — intervention group
Group type: EXPERIMENTAL
Intervention: Food frequency and quantity method
Number of subjects: 76
Study 16566838 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to World Health Organisation guidelines for body mass index, waist circumference, and waist/hip ratio
Number of subjects: 1621
Study 16566838 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term weight gain (women only)
Number of subjects: 1621
Study 14647086 — intervention group
Group type: EXPERIMENTAL
Intervention: 667 mg encapsulated sucralose daily for 13 weeks
Number of subjects: 128
Study 14647086 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose) capsules daily for 13 weeks
Number of subjects: 128
Study 10588126 — intervention group
Group type: EXPERIMENTAL
Intervention: SPIR/FLAIR sequence
Number of subjects: 34
Study 10588126 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced T1-weighted SPIR images
Number of subjects: 34
Study 10588126 — intervention group
Group type: EXPERIMENTAL
Intervention: SPIR/FLAIR technique
Number of subjects: 34
Study 8949786 — intervention group
Group type: EXPERIMENTAL
Intervention: Lomefloxacin 400 mg once a day for three days
Number of subjects: 595
Study 8949786 — intervention group
Group type: COMPARATOR
Intervention: Pefloxacin 800 mg once a day for three days
Number of subjects: 595
Study 2224374 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (5 mg t.d.s.)
Number of subjects: 23
Study 2224374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 2224374 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 23
Study 363216 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly selective vagotomy
Number of subjects: 36
Study 363216 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal vagotomy with pyloroplasty
Number of subjects: 36
Study 363216 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal vagotomy with antrectomy
Number of subjects: 36
Study 30081698 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tazarotene 0.1% after fractional CO2 laser treatment
Number of subjects: 102
Study 30081698 — intervention group
Group type: COMPARATOR
Intervention: Topical tioconazole 28% after fractional CO2 laser treatment
Number of subjects: 102
Study 30081698 — intervention group
Group type: EXPERIMENTAL
Intervention: KOH test and culture results after treatment in Group A
Number of subjects: 102
Study 30081698 — intervention group
Group type: COMPARATOR
Intervention: KOH test and culture results after treatment in Group B
Number of subjects: 102
Study 27987182 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised modified step aerobics training (twice weekly, 1 hour per session) over a period of 6 months
Number of subjects: 27
Study 27987182 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 27
Study 25879367 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS stimulation during radiotherapy (Group S1B)
Number of subjects: 40
Study 25879367 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS stimulation during radiotherapy (Group S1A)
Number of subjects: 40
Study 25879367 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS stimulation after radiotherapy (Group S2)
Number of subjects: 40
Study 25879367 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 40
Study 24727345 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week group-based multicomponent treatment course
Number of subjects: 192
Study 24727345 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 192
Study 22410382 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (5 mg daily for 4 days)
Number of subjects: 275
Study 22410382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study 19588641 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin microsphere gel pump 0.04% (TMG PUMP)
Number of subjects: 0
Study 19588641 — intervention group
Group type: COMPARATOR
Intervention: Tazarotene cream 0.05% (TAZ)
Number of subjects: 0
Study 17616006 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg grape seed extract (calculated as proanthocyanidin)
Number of subjects: 61
Study 17616006 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg grape seed extract (calculated as proanthocyanidin)
Number of subjects: 61
Study 14693623 — intervention group
Group type: EXPERIMENTAL
Intervention: K‐K9 acupressure
Number of subjects: 100
Study 14693623 — intervention group
Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 100
Study 12217604 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2a (40KD)
Number of subjects: 814
Study 9700132 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 ppm O3 for 4 hours on 4 consecutive days
Number of subjects: 15
Study 9700132 — intervention group
Group type: COMPARATOR
Intervention: 0.2 ppm O3 for 4 hours on a single day
Number of subjects: 15
Study 7858359 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual healing
Number of subjects: 24
Study 7858359 — intervention group
Group type: COMPARATOR
Intervention: No active treatment
Number of subjects: 24
Study 3675134 — intervention group
Group type: EXPERIMENTAL
Intervention: mCPP (0.5 mg/kg, orally)
Number of subjects: 12
Study 3675134 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3675134 — intervention group
Group type: EXPERIMENTAL
Intervention: mCPP
Number of subjects: 12
Study 3675134 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (N=20)
Number of subjects: 12
Study 30143478 — intervention group
Group type: EXPERIMENTAL
Intervention: Church-based weight loss intervention with SMS text messages (10 sessions, 6 months)
Number of subjects: 97
Study 30143478 — intervention group
Group type: COMPARATOR
Intervention: SMS text messages related to health conditions (delayed intervention)
Number of subjects: 97
Study 30143478 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of SMS text messages sent
Number of subjects: 97
Study 27426424 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention to reduce alcohol use
Number of subjects: 127
Study 27426424 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported alcohol use
Number of subjects: 127
Study 27426424 — intervention group
Group type: EXPERIMENTAL
Intervention: Semistructured interviews
Number of subjects: 127
Study 25397623 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB)
Number of subjects: 128
Study 25397623 — intervention group
Group type: COMPARATOR
Intervention: Systematic inguinofemoral lymph node dissection (ILND)
Number of subjects: 128